Introduction
In the initial treatment of a critically ill patient, blood pressure, heart rate, urine output, and central venous pressure guide resuscitation. Despite normalization of these variables, global tissue hypoxia may still persist when the cardiorespiratory system is unable to cover metabolic demand adequately [1] . Sustained tissue hypoxia is one of the most important cofactors in the development of multiorgan failure [2] .
Monitoring of the mixed venous oxygen saturation (SvO 2 ) is used as a surrogate for the balance between systemic oxygen delivery and consumption during the treatment of critically ill patients [3] . However, measurement of SvO 2 involves placement of a pulmonary artery catheter with a risk/benefit relationship that is still a matter of controversy [4] [5] [6] . On the other hand, measuring central venous oxygen saturation (ScvO 2 ) requires a central venous catheter, which is routinely inserted in critically ill patients for monitoring of central venous pressure and administration of inotropes/vasopressors and parenteral nutrition. In principle, measuring ScvO 2 reflects the degree of oxygen extraction from the brain and the upper part of the body. Therefore, measurement of ScvO 2 seems to be an attractive alternative to monitoring of SvO 2 because it can be performed more easily and is less risky [3] . Readings may be taken intermittently by blood sampling and co-oximetry, or continuously with a fiberoptic catheter; however, benficial effects on patient outcome have been demonstrated so far only by continuous measurement of ScvO 2 [7] .
Low values of SvO 2 or ScvO 2 indicate a mismatch between oxygen delivery and tissue oxygen need [8] . Monitoring of ScvO 2 has been successfully used as a hemodynamic goal in the management of early sepsis; Rivers et al. [7] demonstrated in a recent prospective randomized study in patients with severe sepsis and septic shock that, in addition to maintaining central venous pressure above 8-12 mmHg, mean arterial pressure above 65 mmHg, and urine output above 0.5 ml/kg per h, the maintenance of a ScvO 2 above 70% resulted in an absolute reduction of mortality by 15%. Thus, the guidelines of the Surviving Sepsis Campaign [9] stated that the use of SvO 2 and ScvO 2 is equivalent in the management of patients with severe sepsis and septic shock. Furthermore, there is interest in evaluating the use of this parameter in other groups of patients, although ScvO 2 values may differ from SvO 2 values, and this difference varies in direction and magnitude with cardiovascular insufficiency.
Pathophysiology of mixed venous oxygen saturation and central venous oxygen saturation
The normal range for SvO 2 , which reflects the balance between systemic oxygen delivery (DO 2 ) and demands, is about 75% (Table 1) . Usually oxygen consumption (VO 2 ) is independent of DO 2 since tissues can maintain oxygen needs by increasing oxygen extraction when DO 2 decreases. However, this mechanism has its limits. SvO 2 decreases when DO 2 has been compromised or systemic oxygen demands have exceeded supply and VO 2 becomes dependent on DO 2 . When compensatory mechanisms are overwhelmed and SvO 2 remains low, then tissue hypoxia occurs, and a rise in serum lactate levels may be observed [10] . Thus decreases in SvO 2 and ScvO 2 represent an increased metabolic stress, because the oxygen demands of the body are not completely met by DO 2 . The causes of a decreasing SvO 2 are multiple: DO 2 does not increase in such a way to cover an increased VO 2 , or DO 2 drops because of decrease in either arterial oxygen content, cardiac output, or both. Importantly, the normal cardiovascular response of increasing VO 2 is to increase oxygen extraction and cardiac output. Thus SvO 2 normally decreases during exercise despite increasing DO 2. Therefore a drop in SvO 2 or ScvO 2 does not necessarily mean that tissue hypoxia occurs. The magnitude of the decrease indicates the extent to which the physiological reserves are stressed (Table 1) . Whereas in otherwise healthy individuals anerobic metabolism may occur when SvO 2 drops below its normal value of 75% to 30-40% for a substantial period of time, patients with chronic heart failure may live with an SvO 2 in this low range without apparent tissue hypoxia, presumably because they have adapted to higher oxygen extraction. These patients can increase their VO 2 only to a limited degree, however, because oxygen extraction is close to its limits, as is cardiac output.
The cardiocirculatory system may be challenged by two different conditions. Firstly, a drop in DO 2 can be induced by anemia, hypoxia, hypovolemia, or heart failure. Secondly, fever, pain, shivering, or stress may also decrease SvO 2 or ScvO 2 by increasing whole-body VO 2 .
Difference between SvO 2 and ScvO 2
Since central venous catheterization is commonly performed for a variety of reasons in critically ill patients, it would be useful if ScvO 2 could function as a surrogate for SvO 2 . The central venous catheter sampling site usually resides in the superior vena cava. Thus central venous blood sampling reflects the venous blood of the upper body but neglects venous blood from the lower body (i.e. intra-abdominal organs). As presented in Fig. 1 systems since they extract different amounts of oxygen. ScvO 2 is usually less than SvO 2 by about 2-3% because overall the lower body extracts less oxygen than the upper body, making inferior vena cava oxygen saturation higher. The primary cause of this lower oxygen extraction is that many of the vascular circuits that drain into the inferior vena cava use blood flow for nonoxidative phosphorylation needs (e.g. renal blood flow, portal flow, hepatic blood flow). However, SvO 2 and ScvO 2 change in parallel when the whole-body ratio of oxygen supply to demand is altered [11] . The difference between the absolute value of ScvO 2 and SvO 2 changes under conditions of shock [12] . In septic shock ScvO 2 often exceeds SvO 2 by about 8% [13 ] . During cardiogenic or hypovolemic shock mesenteric and renal blood flow decreases followed by an increase in oxygen extraction in these organs. In septic shock regional oxygen consumption of the gastrointestinal tract and hence regional oxygen extraction increases despite elevated regional blood flows [14] . On the other hand, cerebral blood flow is maintained over some period in shock. This may result in a delayed and less marked drop of ScvO 2 in comparison to SvO 2 , and the correlation between these two parameters may worsen. Some authors have therefore argued that ScvO 2 cannot be used as surrogate for SvO 2 under conditions of circulatory shock [15] . In any case, ScvO 2 should not be used alone in the assessment of the cardiocirculatory system but combined with other cardiocirculatory parameters and indicators of organ perfusion such as serum lactate concentration and urine output.
Parallel tracking of SvO 2 and ScvO 2
The relationship between SvO 2 and ScvO 2 has been investigated in numerous studies in experimental and clinical settings with controversial conclusions. The number of subjects included ranged from seven [16] to 61 [17] and the number of comparative measurements from 27 [15] to 580 [16] . Interestingly, in some studies there was an unequal number of blood samples compared per subject, which resulted in an imbalanced statistical weight of subjects with excellent or bad correspondence between SvO 2 and ScvO 2 [16, 18, 19] .
In an animal study Schou et al. [19] concluded that during hemodilution SvO 2 and ScvO 2 are interchangeable and that monitoring of ScvO 2 is as useful as monitoring SvO 2 .
In another animal study, SvO 2 increased in pigs after volume loading with 6% hydroxyethyl starch in parallel from 55.0 AE 5.2 to 64.8 AE 9.0% (mean AE SD); CO increased from 2.3 AE 0.4 to 3.5 AE 0.9 l/min and ScvO 2 from 68.2 AE 9.3 to 79.4 AE 7.2% (P < 0.05) [20] . In contrast, during progressive hemodilution, SvO 2 and ScvO 2 remained statistically unchanged until hemoglobin concentration was reduced by 50%. The authors suggest that volume therapy should be directed to maintain a high venous oxygen saturation rather than a change in cardiac output. Reinhart et al. [21] demonstrated in dogs a close tracking between continuously measured SvO 2 and ScvO 2 across a wide range of hemodynamic conditions, including hemorrhagic shock and hypoxia. Of note in both of the latter animal studies is that the correlation coefficient was 0.97 and SvO 2 values were lower than ScvO 2 . Recently, Reinhart et al. [13 ] confirmed his findings in critically ill patients (Fig. 2) . On the other hand, Chawla et al. [22] showed in a mixed group of 53 critically ill patients that SvO 2 was consistently lower than ScvO 2 (P < 0.0001), with a mean bias of À5. up to 6% [25] . This observation may be explained by the effect of inhalation anesthetics of increasing cerebral blood flow and therefore reducing cerebral oxygen extraction. This results in a higher SO 2 in the superior vena cava. A similar effect can be observed in patients with elevated intracranial pressures where cerebral trauma and barbiturate coma may reduce cerebral metabolism. Patients with elevated intracranial pressures revealed the highest difference between SvO 2 and ScvO 2 [13 ] .
Clinical application of ScvO 2 and SvO 2
The importance of ScvO 2 and SvO 2 monitoring has been extended in patients with different kinds of shock and in patients after major surgery.
Severe sepsis and septic shock
In sepsis tissue hypoxia is one of the most important cofactors in the development of multiorgan failure [2]. Rivers et al. [7] demonstrated in patients with severe sepsis or septic shock that an early and aggressive resuscitation guided by continuous ScvO 2 monitoring in addition to central venous pressure and mean arterial pressure reduced the 28-day mortality rate from 46.5 to 30.5% (P ¼ 0.009) [7] . Compared with the conventionally treated group, the ScvO 2 group received more fluids, more dobutamine, and more blood transfusion during the first 6 h. This resulted in a faster and better improvement of organ function in the ScvO 2 group. The mean ScvO 2 of this group was 77%, of whom fewer than half required any vasopressor therapy. Whether the frequently applied clinical practice of intermittent ScvO 2 monitoring is as effective as the fiberoptic continuous ScvO 2 monitoring applied in the study by River et al. [7] is unknown and needs to be investigated.
In a large prospective study Gattinoni et al. [26] reported that a goal-directed therapy targeting to SvO 2 of more than 70% over 5 days did not result in lower mortality compared with controls (63.8 versus 62.3%). Of note, in their study only 66.7% of patients reached the target goal the treatment arm and the mortality in this subgroup of patients revealed 39.0%. In a recent retrospective study Varpula et al. [27] assessed the impact of hemodynamic variables on 111 septic shock patients, using 30-day mortality as the primary end point. They showed that the most important hemodynamic variables relevant to outcome are mean arterial pressure and lactate levels in the first 6 h and mean arterial pressure, SvO 2 , and central venous pressure in the first 48 h. A mean arterial pressure of 65 mmHg and SvO 2 of 70% revealed the best predictive threshold level for mortality of septic shock patients. The retrospective nature of this study is a limitation, but it nicely confirms recommendations of the Surviving Sepsis Campaign [9] for hemodynamic treatment in septic shock to be guided by central venous pressure, mean arterial pressure, and ScvO 2 .
Major surgery
Goal-directed therapy has been applied in the peri-operative situation usually directed by the pulmonary arterial catheter. Several studies reported a reduction of perioperative morbidity and mortality [28] [29] [30] [31] . Early goaldirected therapy often results in a generous fluid administration and b-adrenergic agents such as dobutamine or dopexamine. Recently, Pearse et al. [32] demonstrated that goal-directed therapy can be applied successfully in the intensive care unit after major surgery. They used fluids and dopexamine to increase DO 2 (to a target of 600 ml/min per m 2 ) for 8 h. The DO 2 target was achieved in 80% of the goal-directed therapy group and in 45% of the control group. Fewer patients developed complications in the goal-directed therapy group than in the control group (this was the primary outcome of the study), leading to a shortened hospital stay. Mortality (at 28 days) was similar in both groups and lower than the mortality predicted by the P-POSSUM score (actual 9.7% compared with predicted 18.5% in goal-directed therapy and actual 11.7% compared with predicted 13.7% in the control group). Pearse et al. [33 ] also measured ScvO 2 in most of the patients investigated in their study assessing the efficacy of goal-directed therapy. They reported that ScvO 2 fluctuated over the first 8 h post-operative period, but not always associated with changes in DO 2 , suggesting that oxygen consumption is also an important determinant of ScvO 2 [33 ] . Furthermore, the lowest ScvO 2 was independently associated with post-operative complications (odds ratio, 0.94; range, 0.89-0.98; P ¼ 0.007). In their cohort of patients a ScvO 2 cut-off value of 64.4% (sensitivity, 67%; specificity, 56%) could be identified to discriminate patients with a complicated or uncomplicated post-operative course. Pearse et al. [33 ] defined those in whom the lowest ScvO 2 value was 64.4% or below as the low ScvO 2 group and those in whom the lowest value was above 64.4% as the high ScvO 2 group. Trends in ScvO 2 are presented in Fig. 3 This impressive study needs to be assessed cautiously in the context of the limitations of a single-center study before entering into a large interventional multi-center study based on the use of ScvO 2 [37] .
Conclusion
The beauty of central venous oximetry is that it only needs the insertion of a central venous catheter; hence all patients eligible for a central venous catheter may theoretically benefit from this parameter. There is a good correlation between ScvO 2 and SvO 2 under non-shock conditions. During the state of circulatory shock, however, ScvO 2 does not always exactly mirror SvO 2 . However, changes of both parameters occur mostly in a parallel manner. Furthermore, changes in SvO 2 due to therapeutic interventions are well reflected in changes of ScvO 2 . Based on the evidence available, the primary indication for the use of central venous oximetry is as part of the early resuscitation in severe septic and septic shock patients.
There is new evidence in patients after major surgery where the use of central venous oximetry was proven to be associated with outcome. As so often is the case, further research is needed to elucidate the efficacy of venous oximetry. To be conclusive these studies must distinguish between different groups of patients, such as those with heart failure or trauma. In these groups of patients optimal target levels need to be evaluated. Last but not least, the question needs to be answered as to whether an intermittent measurement using central venous blood gas analysis is as effective as continuous measurement of ScvO 2 using fiberoptic catheters.
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